0.6222

3.11% 0.0175

Amarin Corp Adr (AMRN)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Amarin Corp Adr stock is traded at $0.6222, with a volume of 562.31K. It is up +3.11% in the last 24 hours and up +2.92% over the past month. Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Previous Close:

$0.6047

Open:

$0.6047

24h Volume:

562.31K

Relative Volume:

0.61

Market Cap:

$253.53M

Revenue:

$306.91M

Net Income/Loss:

$-59.11M

P/E Ratio:

-7.0785

EPS:

-0.0879

Net Cash Flow:

$6.35M

1W Performance:

+1.86%

1M Performance:

+2.92%

6M Performance:

-31.48%

1Y Performance:

-14.38%

1-Day Range:

$0.6042

$0.6295

1-Week Range:

$0.5606

$0.65

52-Week Range:

$0.555

$1.37

Amarin Corp Adr Stock (AMRN) Company Profile

Name

Amarin Corp Adr

Sector

Healthcare (1181)

Industry

Drug Manufacturers - General (18)

Phone

353 1 6699 020

Address

SPACES SOUTH DOCKLANDS, BLOCK C, DUBLIN 2

Employee

275

Twitter

@amarincorp

Next Earnings Date

2024-10-30

Latest SEC Filings

AMRN's Discussions on Twitter

Amarin Corp Adr Stock (AMRN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-20-23	Resumed	JP Morgan	Underweight
Oct-25-23	Downgrade	Jefferies	Buy → Hold
Jan-06-23	Upgrade	Jefferies	Hold → Buy
May-06-22	Downgrade	JP Morgan	Neutral → Underweight
May-05-22	Downgrade	H.C. Wainwright	Buy → Neutral
May-05-22	Downgrade	SVB Leerink	Outperform → Mkt Perform
May-04-22	Downgrade	Northland Capital	Outperform → Market Perform
May-12-21	Downgrade	Goldman	Neutral → Sell
Sep-29-20	Resumed	JP Morgan	Neutral
Aug-26-20	Initiated	Piper Sandler	Overweight
May-05-20	Initiated	Northland Capital	Outperform
Mar-31-20	Downgrade	Goldman	Buy → Neutral
Mar-31-20	Downgrade	Jefferies	Buy → Hold
Mar-31-20	Upgrade	Oppenheimer	Underperform → Perform
Mar-13-20	Upgrade	Goldman	Neutral → Buy
Mar-02-20	Initiated	Cowen	Outperform
Feb-18-20	Upgrade	Citigroup	Neutral → Buy
Jan-06-20	Initiated	JP Morgan	Neutral
Dec-16-19	Downgrade	Stifel	Buy → Hold
Nov-20-19	Initiated	Oppenheimer	Underperform
Nov-18-19	Downgrade	Citigroup	Buy → Neutral
Nov-15-19	Reiterated	SVB Leerink	Outperform
Oct-31-19	Initiated	Aegis Capital	Buy
Oct-15-19	Initiated	Goldman	Neutral
Aug-14-19	Initiated	SVB Leerink	Outperform
Jul-09-19	Reiterated	Jefferies	Buy
Jun-17-19	Initiated	ROTH Capital	Buy
Mar-22-19	Initiated	Stifel	Buy

View All

Amarin Corp Adr Stock (AMRN) Latest News

Oct 31, 2024

Amarin's Q3 Earnings In Line, Revenues Fall Shy Of Estimates - Barchart

Oct 31, 2024

Amarin Plc (AMRN) Q3 2024 Earnings Call Transcript - AOL

Oct 31, 2024

Oct 25, 2024

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - MSN

Oct 25, 2024

Oct 24, 2024

Amarin stock plunges to 52-week low of $0.56 amid market challenges - Investing.com India

Oct 24, 2024

Oct 18, 2024

European Equities Traded in the US as American Depositary Receipts Decline Tuesday - MSN

Oct 18, 2024

Oct 15, 2024

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading - MSN

Oct 15, 2024

Oct 14, 2024